Dr. Rashmi Arun Jadhav, MD

Dr. Jadhav practices at Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health.

Dr. Jadhav's NPI, 1740778364, was assigned on April 30, 2018. Dr. Jadhav holds District of Columbia license MD048986.

Dr. Jadhav's primary practice is Newark Beth Israel Medical Center, at 201 Lyons Ave, Newark, NJ 07112 in Essex County. The practice phone is (973) 926-7000.

Dr. Jadhav's primary practice is Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health. Dr. Jadhav is also affiliated with MedStar Washington Hospital Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Jadhav to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jadhav practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Jadhav's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Jadhav's licenses on file in 3 states: District of Columbia, Maryland and New Jersey.

CMS data shows 440 Medicare services from Dr. Jadhav across 3 procedure codes in 2024, for 446 Medicare patients. Medicare paid $63,244 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 446 Medicare patients who saw Dr. Jadhav in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jadhav's median patient age at 60, with 56% women.

In 2024, Dr. Jadhav wrote 114 Medicare Part D claims for 74 patients. 94% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $146 in total drug cost. In 2023, CMS named 36 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Jadhav for performance year 2024, reported as part of a group. Dr. Jadhav accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Jadhav, published from 2011 to 2015. 2011 was the busiest year, with 3. Dr. Jadhav's most frequent co-authors are Erika Vogel Smith, MD, James Russell, MD and Russell Stevens Terry, MD.

CMS Open Payments shows 5 general payments to Dr. Jadhav from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. CSL Behring paid the most, $108.